Zobrazeno 1 - 8
of 8
pro vyhledávání: '"ZI-XUE XUAN"'
Autor:
Xiao-hong Mao, Qiang Ye, Guo-bing Zhang, Jin-ying Jiang, Hong-ying Zhao, Yan-fei Shao, Zi-qi Ye, Zi-xue Xuan, Ping Huang
Publikováno v:
World Journal of Surgical Oncology, Vol 19, Iss 1, Pp 1-11 (2021)
Abstract Background Aberrant DNA methylation is significantly associated with breast cancer. Methods In this study, we aimed to determine novel methylation biomarkers using a bioinformatics analysis approach that could have clinical value for breast
Externí odkaz:
https://doaj.org/article/63c3e178533043ad818e9a391568b353
Autor:
Lin-qing Liu, Shi-bing Wang, Yan-fei Shao, Jia-na Shi, Wei Wang, Wan-yuan Chen, Zi-qi Ye, Jin-ying Jiang, Qing-xia Fang, Guo-bing Zhang, Zi-xue Xuan
Publikováno v:
Biomedicine & Pharmacotherapy, Vol 118, Iss , Pp - (2019)
Bevacizumab (BEV) is widely used for the treatment of patients with recurrent glioblastoma (GBM), but recent evidence demonstrated that BEV induced cytoprotective autophagy, which allows tumor cells to survive. Hydroxychloroquine (HCQ) inhibits lysos
Externí odkaz:
https://doaj.org/article/5d6248ab89b54c279a00add5f176e141
Publikováno v:
World Journal of Surgical Oncology. 9/2/2016, Vol. 14, p1-9. 9p.
Fully human VEGFR2 monoclonal antibody BC001 attenuates tumor angiogenesis and inhibits tumor growth
Autor:
Xiao-Wen Li, Shanshan Wang, Shoujun Yuan, Qi Zhang, Ye Yuan, Zi-Xue Xuan, Chengwang Xu, Linna Li, Yinghong An, Dexuan Yang
Publikováno v:
International Journal of Oncology. 45:2411-2420
The critical role of VEGFR2 in tumor neovascularization and progression has allowed the design of clinically beneficial therapies based on it. Here we show that BC001, a new fully human anti-VEGFR2 monoclonal antibody, inhibits VEGF-stimulated endoth
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9e11f05b64c0ab140302563656792d97
https://doi.org/10.3892/ijo.2014.2690
https://doi.org/10.3892/ijo.2014.2690
Publikováno v:
International Journal of Molecular Sciences, Vol 14, Iss 3, Pp 4722-4733 (2013)
International Journal of Molecular Sciences
Volume 14
Issue 3
Pages 4722-4733
International Journal of Molecular Sciences
Volume 14
Issue 3
Pages 4722-4733
Oral or gastrointestinal mucositis is a frequent phenomenon in cancer patients receiving chemotherapy or radiotherapy. In addition, several clinical investigations have demonstrated in recent years that riboflavin laurate has the potential to protect
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::17cb02e6fd5314dcb2e08cd866e0736e
http://www.mdpi.com/1422-0067/14/3/4722
http://www.mdpi.com/1422-0067/14/3/4722
Publikováno v:
World Journal of Surgical Oncology
Background Non-small cell lung cancer (NSCLC) is the most frequent cause of cancer deaths worldwide. The targeted therapy had made important progress in recent years, but few potential predictive biomarkers for prognosis of NSCLC patients were identi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5ce7617a273fffbf63a5ec3aa89f844b
https://doi.org/10.1186/s12957-016-0992-4
https://doi.org/10.1186/s12957-016-0992-4
Autor:
Yang Yang, Shou-Jun Yuan, Xingguo Mei, Wei Gong, Dexuan Yang, Zi-Xue Xuan, Hui Zhang, Yanfang Yang, Zhiyuan Wang, Xiangyang Xie, Shanshan Wang
Publikováno v:
Journal of pharmaceutical sciences. 103(7)
A novel thermosensitive liposome (TL) containing docetaxel (DTX) was designed to enhance DTX-targeted delivery and antitumor effect. TL loading DTX (DTX-TL) were prepared by thin film hydration. The mean particle size of the liposomes was about 100 n
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f24af9d83dfd656180a3d27fea904cfc
https://pubmed.ncbi.nlm.nih.gov/24846075
https://pubmed.ncbi.nlm.nih.gov/24846075
Autor:
ZI-XUE XUAN, LIN-NA LI, QI ZHANG, CHENG-WANG XU, DE-XUAN YANG, YE YUAN, YING-HONG AN, SHAN-SHAN WANG, XIAO-WEN LI, SHOU-JUN YUAN
Publikováno v:
International Journal of Oncology; 2014, Vol. 45 Issue 6, p2411-2420, 10p